ABS Direct Equity Fund LLC
Position in CRL — Charles River Laboratories International, Inc.
CIK 1729347
Stamford, CT
Position in CRL
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$51,481
-$121,019 QoQ
Shares Held
227
-77.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#428
of 564 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026ABS Direct Equity Fund LLC holds $2,543,916 across 4 Diagnostics & Research names. CRL ranks #3 (2.0% of the industry book) .
All Filings in CRL
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $51,481 | 227 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $172,500 | 1,000 | Shares | Other | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||